Australia's most trusted
source of pharma news
Tuesday, 15 July 2025
Posted 19 May 2023 AM
Bayer ANZ has unveiled a new pharmaceutical operating model based on more flexible, 'squad-based' working, resulting in a shakeup of the current team - including an undisclosed number of redundancies.
The company said the transformation is designed to deepen customer-centricity, improve the speed at which specialised innovation is delivered to patients and foster a future-ready organisation, where employees continually develop.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.